{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:47:40Z","timestamp":1778636860340,"version":"3.51.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/gme.0b013e3181a181b8","type":"journal-article","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T07:14:00Z","timestamp":1251530040000},"page":"950-955","source":"Crossref","is-referenced-by-count":31,"title":["Relationships among serum receptor of nuclear factor-\u03baB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineraldensity in postmenopausal women"],"prefix":"10.1097","volume":"16","author":[{"given":"Iraj","family":"Nabipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Vahdat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Assadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mojtaba","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Moradhaseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Sanjdideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Obeidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210227","first-page":"268","article-title":"The OPG\/RANKL\/RANK system in metabolic bone diseases.","volume":"4","author":"Hofbauer","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"R2-20-20210227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.maturitas.2008.04.005","article-title":"Advances in bone biology and new treatments for bone loss.","volume":"60","author":"Gallagher","year":"2008","journal-title":"Maturitas"},{"key":"R3-20-20210227","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"R4-20-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"R5-20-20210227","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling.","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"R6-20-20210227","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","article-title":"Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure.","volume":"111","author":"Ueland","year":"2005","journal-title":"Circulation"},{"key":"R7-20-20210227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4933-2-14","article-title":"Osteoporosis, inflammation and ageing.","volume":"2","author":"Ginaldi","year":"2005","journal-title":"Immun Ageing"},{"key":"R8-20-20210227","first-page":"113","article-title":"Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.","volume":"12","author":"McCormick","year":"2007","journal-title":"Altern Med Rev"},{"key":"R9-20-20210227","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.","volume":"93","author":"Ding","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20-20210227","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/archinte.166.22.2495","article-title":"High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.","volume":"166","author":"Schett","year":"2006","journal-title":"Arch Intern Med"},{"key":"R11-20-20210227","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.296.11.1353","article-title":"High-sensitivity C-reactive protein and fracture risk in elderly women.","volume":"296","author":"Pasco","year":"2006","journal-title":"JAMA"},{"key":"R12-20-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor B ligand and osteoprotegerin regulation of bone remodeling in health and disease.","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr Rev"},{"key":"R13-20-20210227","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/gme.0b013e31816665a7","article-title":"Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.","volume":"15","author":"Nabipour","year":"2008","journal-title":"Menopause"},{"key":"R14-20-20210227","first-page":"1","article-title":"Assesment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization, Geneva.","volume":"843","year":"1994","journal-title":"Technical Report Series"},{"key":"R15-20-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/JME-08-0003","article-title":"Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.","volume":"40","author":"Mencej","year":"2008","journal-title":"J Mol Endocrinol"},{"key":"R16-20-20210227","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/gme.0b013e31802d976f","article-title":"Association between osteoprotegerin (OPG), receptor activator of nuclear factor-B (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.","volume":"14","author":"Kim","year":"2007","journal-title":"Menopause"},{"key":"R17-20-20210227","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R18-20-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-004-0007-2","article-title":"Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75.","volume":"76","author":"Liu","year":"2005","journal-title":"Calcif Tissue Int"},{"key":"R19-20-20210227","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00198-005-1844-1","article-title":"The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.","volume":"16","author":"Mezquita-Raya","year":"2005","journal-title":"Osteoporos Int"},{"key":"R20-20-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/gme.0b013e318133a153","article-title":"Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor B ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.","volume":"15","author":"Kim","year":"2008","journal-title":"Menopause"},{"key":"R21-20-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03345584","article-title":"Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women.","volume":"31","author":"Uemura","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"R22-20-20210227","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jama.291.9.1108","article-title":"Soluble RANKL and risk of nontraumatic fracture.","volume":"291","author":"Schett","year":"2004","journal-title":"JAMA"},{"key":"R23-20-20210227","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1210\/jc.2007-0646","article-title":"Clinical review: The role of receptor activator of nuclear factor-B (RANK)\/RANK ligand\/osteoprotegerin: clinical implications.","volume":"92","author":"Vega","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20-20210227","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2007-2492","article-title":"Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.","volume":"93","author":"Samelson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1530\/EJE-06-0753","article-title":"The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor B legend with bone mineral density in older adults: the Rancho Bernardo study.","volume":"156","author":"Stern","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R26-20-20210227","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"R27-20-20210227","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00296-007-0514-3","article-title":"sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis.","volume":"28","author":"Hein","year":"2008","journal-title":"Rheumatol Int"},{"key":"R28-20-20210227","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/eje.1.02099","article-title":"Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.","volume":"154","author":"Mazziotti","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R29-20-20210227","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-B p50 and p52 regulate receptor activator of NF-B ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.","volume":"282","author":"Yamashita","year":"2007","journal-title":"J Biol Chem"},{"key":"R30-20-20210227","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1074\/jbc.M706415200","article-title":"Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.","volume":"283","author":"Yao","year":"2008","journal-title":"J Biol Chem"},{"key":"R31-20-20210227","first-page":"329","article-title":"Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females.","volume":"97","author":"Ganesan","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"R32-20-20210227","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jocd.2007.06.002","article-title":"Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women.","volume":"10","author":"Bhupathiraju","year":"2007","journal-title":"J Clin Densitom"},{"key":"R33-20-20210227","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","article-title":"Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.","volume":"16","author":"Koh","year":"2005","journal-title":"Osteoporos Int"},{"key":"R34-20-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2265.2007.02853.x","article-title":"Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women.","volume":"67","author":"Kim","year":"2007","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200916050-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:31:54Z","timestamp":1618277514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200916050-00020"}},"subtitle":["osteoimmunity versus osteoinflammatory"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181a181b8","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}